Cause of death, by non-communicable diseases, ages 5-14 in Syria
Syria: Cause of death, by non-communicable diseases, ages 5-14 was 30.4% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, ages 5-14 in Syria, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 5-14.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 5-14 in Syria is 30.4%, measured in 2021.
Compared with earlier readings it is up 8.7% on the previous year and down 28.4% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14 in Syria peaked at 47.0% in 2000 and was at its lowest, 13.2%, in 2019.
That places Syria 116th out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 5-14 in Syria, year by year
| Year | % of total deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 47.0% | — |
| 2010 | 42.5% | -9.7% |
| 2015 | 14.6% | -65.7% |
| 2019 | 13.2% | -9.4% |
| 2020 | 28.0% | +112.2% |
| 2021 | 30.4% | +8.7% |
Syria compared with similar countries
- Syria's 30.4% is above the median for low income countries, which is 21.1%, 1.4× the median. (25 countries reporting)
- Syria's 30.4% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 42.5%, 71% of the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 47.0% | 47.0% | 47.0% | 1 |
| 2010s | 23.4% | 13.2% | 42.5% | 3 |
| 2020s | 29.2% | 28.0% | 30.4% | 2 |
Countries ranked near Syria
More health data for Syria
- Un projection of annual infant deaths, annual growth rate -2.1 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8632 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,122 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,491 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 7.54 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2022)
- Population ages 00-04, female, per capita 0.0503 units per person (2025)
- Population ages 00-04, male, annual growth rate 7.65 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2022)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14 in Syria?
- Cause of death, by non-communicable diseases, ages 5-14 in Syria was 30.4% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14 recorded in Syria?
- The highest recorded value was 47.0% in 2000.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14 recorded in Syria?
- The lowest recorded value was 13.2% in 2019.
- How does Syria rank for cause of death, by non-communicable diseases, ages 5-14?
- Syria ranks 116th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14 rising or falling in Syria?
- Over the last ten years it is down 28.4%. The long-run trend across the full record is falling.
- Where does this Syria data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.